ORGOVYX® (relugolix tablets, 120 mg) is indicated for the treatment of adult patients with advanced prostate cancer.2
EFFICACY PROFILE
Evaluate the ORGOVYX® efficacy data from the HERO study:
Testosterone suppression
data (Day 29 to Week 48)
Learn Moredata (Day 29 to Week 48)
Testosterone suppression
data at Day 15Learn More
data at Day 15Learn More
Testosterone
recovery dataLearn More
recovery dataLearn More
DOSING AND
ADMINISTRATION
Find dosing and administration information related to ORGOVYX®.
About ORGOVYX®HERO STUDY
Learn more about the HERO study, which evaluated ORGOVYX® in advanced prostate cancer patients.
Learn More